Your browser doesn't support javascript.
loading
Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia.
Aoki, Yuki; Watanabe, Takashi; Saito, Yoriko; Kuroki, Yoko; Hijikata, Atsushi; Takagi, Masatoshi; Tomizawa, Daisuke; Eguchi, Mariko; Eguchi-Ishimae, Minenori; Kaneko, Akiko; Ono, Rintaro; Sato, Kaori; Suzuki, Nahoko; Fujiki, Saera; Koh, Katsuyoshi; Ishii, Eiichi; Shultz, Leonard D; Ohara, Osamu; Mizutani, Shuki; Ishikawa, Fumihiko.
Affiliation
  • Aoki Y; Laboratory for Human Disease Models RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan;
  • Watanabe T; Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan;
  • Saito Y; Laboratory for Human Disease Models RIKEN Center for Integrative Medical Sciences, Yokohama, Japan;
  • Kuroki Y; Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan;
  • Hijikata A; Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan;
  • Takagi M; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan;
  • Tomizawa D; Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan;
  • Eguchi M; Department of Pediatrics, Ehime University Graduate School of Medicine, Ehime, Japan;
  • Eguchi-Ishimae M; Department of Pediatrics, Ehime University Graduate School of Medicine, Ehime, Japan;
  • Kaneko A; Laboratory for Human Disease Models RIKEN Center for Integrative Medical Sciences, Yokohama, Japan;
  • Ono R; Laboratory for Human Disease Models RIKEN Center for Integrative Medical Sciences, Yokohama, Japan;
  • Sato K; Laboratory for Human Disease Models RIKEN Center for Integrative Medical Sciences, Yokohama, Japan;
  • Suzuki N; Laboratory for Human Disease Models RIKEN Center for Integrative Medical Sciences, Yokohama, Japan;
  • Fujiki S; Laboratory for Human Disease Models RIKEN Center for Integrative Medical Sciences, Yokohama, Japan;
  • Koh K; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan;
  • Ishii E; Department of Pediatrics, Ehime University Graduate School of Medicine, Ehime, Japan;
  • Shultz LD; The Jackson Laboratory, Bar Harbor, ME; and.
  • Ohara O; Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; Kazusa DNA Research Institute, Kisarazu, Chiba, Japan.
  • Mizutani S; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan;
  • Ishikawa F; Laboratory for Human Disease Models RIKEN Center for Integrative Medical Sciences, Yokohama, Japan;
Blood ; 125(6): 967-80, 2015 Feb 05.
Article in En | MEDLINE | ID: mdl-25538041

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression Regulation, Leukemic / Oncogene Proteins, Fusion / Antigens, CD34 / Myeloid-Lymphoid Leukemia Protein / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Diagnostic_studies Limits: Animals / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Blood Year: 2015 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression Regulation, Leukemic / Oncogene Proteins, Fusion / Antigens, CD34 / Myeloid-Lymphoid Leukemia Protein / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Diagnostic_studies Limits: Animals / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Blood Year: 2015 Type: Article